Skip to content

Effectiveness of a Ready-to-Use-Food (RUF) Supplement to Prevent Acute Child Malnutrition

Effectiveness and Cost-effectiveness of a Ready-to-Use-Food (RUF) Supplement to Prevent Acute Malnutrition in Children Between 6-36 Months in Urban Chad

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01154595
Acronym
PREAMA
Enrollment
2000
Registered
2010-07-01
Start date
2010-06-30
Completion date
2011-02-28
Last updated
2011-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Child, Malnutrition

Keywords

moderate acute malnutrition, prevention, Lipid-based supplement

Brief summary

The overall objective of this project is to assess the effectiveness and cost-effectiveness of RUF (ready-to-Use Food, Plumpy Doz(r)) to prevent moderate acute malnutrition in children aged 6-36 months if embedded in a program of conditional household food assistance.

Interventions

DIETARY_SUPPLEMENTPlumpy Doz(r) - Ready-to-Use Food

47g Plumpy Doz(r) per day per child

BEHAVIORALFood-for-Training

Conditional family food supplementation (sugar, sorghum, beans, iodized salt, vegetable oil) 1800 kcal/person/day in function of attendance and participation in a sensitization program covering various themes on household, water and disease management, hygiene promotion, sanitation and dietary practices for children.

Sponsors

University Ghent
CollaboratorOTHER
Action Contre la Faim
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Months to 36 Months
Healthy volunteers
Yes

Inclusion criteria

* WH≥80% of median of NCHS reference without bilateral pitting oedema; * Age ≥ 6 months and ≤36 months; * Member of a household with a dependency ratio \>4; * Not planning to leave the study zone for the coming 5 months;

Exclusion criteria

* Not showing appetite; * Age \< 6 months or age \> 36 months * Weight-for-Height Z-score \<-2 and/or the presence of bilateral pitting oedema in children 6-36 months; * Member of a household with a dependency ration ≤ 4; * Clinical complications * Presence of chronic illness, cardiac disease, congenital abnormalities, cancer; * Being allergic to one of the ingredients of the RUF.

Design outcomes

Primary

MeasureTime frame
Cumulative wasting incidence, hemoglobin concentrationmonthly

Secondary

MeasureTime frame
weight gainmonthly
time to become wastedmonthly
default ratemonthly
RUF acceptabilitymonthly
dietary intakemonthly

Countries

Chad

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026